or Try an Advanced Search...

    Technical Analysis for GLMD - Galmed Pharmaceuticals Ltd.

    Grade Last Price % Change Price Change
    F 2.84 -4.05% -0.12
    GLMD closed down 1.33 percent on Wednesday, November 20, 2024, on 1 percent of normal volume.
    3 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical GLMD trend table...
    Date Alert Name Type % Chg
    Narrow Range Bar Range Contraction -4.05%
    Earnings Movers Other -4.05%
    Wide Bands Range Expansion -4.05%
    Narrow Range Bar Range Contraction -5.33%
    Wide Bands Range Expansion -5.33%
    Hammer Candlestick Bullish -3.40%
    Narrow Range Bar Range Contraction -3.40%
    Wide Bands Range Expansion -3.40%
    Oversold Stochastic Weakness -3.40%
    Narrow Range Bar Range Contraction -3.07%
    Older End-of-Day Signals for GLMD ...

       Recent Intraday Alerts

    Alert Time
    60 Minute Opening Range Breakdown about 3 hours ago
    Down 5% about 4 hours ago
    Down 3% about 4 hours ago
    Fell Below Previous Day's Low about 4 hours ago
    Down 2 % about 4 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    GLMD Chart by TradingView
    Basic chart:

    Profile

    GalMed Medical Research Ltd. researches and develops proprietary drugs for the treatment of lipid metabolism related diseases. The company has developed a series of proprietary fatty acid bile-acid conjugates (FABACs) which selectively inhibit the enzyme Stearoyl-CoA Desaturase (SCD1), a key regulator in lipid metabolism. It's flagship clinical compound Aramchol (arachidyl amido cholanoic acid), has the potential to modify several of the key disorders related to lipid metabolism, including fatty liver, gallstones, diabetes, hyperlipidemia, cancer, and alzheimer's disease. The company is based in Tel Aviv, Israel. GalMed Medical Research Ltd. operates as a subsidiary of Galmed International Ltd.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Cancer Acid Diabetes Alzheimer's Disease Lipid Medical Research Metabolism Hepatology Fatty Acids Fatty Liver Hyperlipidemia

    Is GLMD a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 15 Galmed Pharmaceuticals: Q3 Earnings Snapshot
    Nov 14 Galmed files for $200M mixed securities shelf
    Oct 21 Galmed Pharmaceuticals files for offering of common stock
    Oct 2 EXCLUSIVE: Top 20 Most-Searched Tickers On Benzinga Pro In September 2024 – Where Do Tesla, Nvidia, Apple, DJT Stock Rank?
    Sep 25 Galmed publishes Results from Aramchol Phase 3 Open Label part in Hepatology
    Sep 19 Galmed Announces an Expansion of its Activities to Cancer and major Cardiometabolic Diseases
    Sep 18 Why Intuitive Machines Shares Are Trading Higher By Around 41%; Here Are 20 Stocks Moving Premarket
    Sep 17 Why Intel Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
    Aug 30 Galmed Pharmaceuticals files to sell 416,667 of ordinary shares for holders
    Aug 21 Why Keysight Technologies Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket
    See more GLMD news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 23.8
    52 Week Low 2.73
    Average Volume 3,334,254
    200-Day Moving Average 4.24
    50-Day Moving Average 4.69
    20-Day Moving Average 3.26
    10-Day Moving Average 2.99
    Average True Range 0.43
    RSI (14) 39.76
    ADX 17.88
    +DI 23.38
    -DI 20.68
    Chandelier Exit (Long, 3 ATRs) 3.51
    Chandelier Exit (Short, 3 ATRs) 4.03
    Upper Bollinger Bands 3.97
    Lower Bollinger Band 2.55
    Percent B (%b) 0.29
    BandWidth 43.39
    MACD Line -0.38
    MACD Signal Line -0.42
    MACD Histogram 0.0399
    Fundamentals Value
    Market Cap 11.86 Million
    Num Shares 4.01 Million
    EPS -3.02
    Price-to-Earnings (P/E) Ratio -0.98
    Price-to-Sales 0.00
    Price-to-Book 0.09
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 3.26
    Resistance 3 (R3) 3.26 3.15 3.21
    Resistance 2 (R2) 3.15 3.08 3.15 3.19
    Resistance 1 (R1) 3.06 3.03 3.01 3.06 3.18
    Pivot Point 2.95 2.95 2.93 2.96 2.95
    Support 1 (S1) 2.86 2.88 2.81 2.86 2.74
    Support 2 (S2) 2.75 2.83 2.76 2.73
    Support 3 (S3) 2.66 2.75 2.71
    Support 4 (S4) 2.66